Skip to main content
. 2022 Feb 28;10(3):378. doi: 10.3390/vaccines10030378

Figure 11.

Figure 11

Salt bridges formed between receptor and vaccine: (A) TLR4-agonist vaccine with TLR4; (B) β-defensin vaccine with TLR4; (C) 50S ribosomal protein L7/L12 vaccine with TLR4.